Literature DB >> 28589668

Strongly positive anti-CCP antibodies in patients with sacroiliitis or reactive arthritis post-E. coli infection: A mini case-series based review.

Miljyot Singh Sangha1,2, Matthew Liam Wright2, Coziana Ciurtin2.   

Abstract

We report here on four cases of patients with strongly positive anti-citrullinated cyclic peptides (anti-CCP) antibodies and clinical features of seronegative spondyloarthritis (SpA) and reactive arthritis. The four patients had various clinical presentations: one had an initial diagnosis of seropositive rheumatoid arthritis (RA) with involvement of the sacroiliac joints (similar to previous reports of the association of two diseases); one had a clinical picture of reactive arthritis following an episode of an Escherichia coli positive urinary tract infection; and two had asymmetrical sacroiliitis (SII), but no evidence of peripheral joint involvement (never reported before). In all cases, high titers of anti-CCP antibodies were found. We present a comparison of the clinical manifestations, radiographic features and treatment regimens of these cases. Our report supports previous literature data of possible overlap existing between RA and SpA, but also presents for the first time the association of high titers of anti-CCP antibodies with SII and reactive arthritis in patients with no peripheral small joint involvement.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  ankylosing spondylitis; clinical aspects

Mesh:

Substances:

Year:  2017        PMID: 28589668     DOI: 10.1111/1756-185X.13113

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  3 in total

Review 1.  Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

2.  Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC).

Authors:  Riitta Tuompo; Tinja Lääveri; Timo Hannu; Sari H Pakkanen; Juha Kirveskari; Marjatta Leirisalo-Repo; Anu Kantele
Journal:  Ann Rheum Dis       Date:  2020-03-16       Impact factor: 19.103

Review 3.  B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Rick Wilbrink; Anneke Spoorenberg; Gwenny M P J Verstappen; Frans G M Kroese
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.